Stock Details
BSX is Boston Scientific Corporation's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 40.85$. Average daily volumn in 3 months 6.71M. Market cap 55.45B



Stock symbol : BSX. Exchange : NYSE. Currency : USD
Lastest price : 38.73$. Total volume : 10.03M. Market state CLOSED
Click reload if you want to check the lastest price on market!!!

Boston Scientific Corporation (BSX)
Last Price
38.73$
Change
-0.61
Volume
10.03M

Previous Close39.34
Open39.40
Day Range38.72-39.99
Bid38.32 x 1k
Ask38.90 x 1.1k
Volume10.03M
Average Volume6.71M
Market Cap55.45B
Beta0.85
52 Week Range34.98-47.50
Trailing P/E67.95
Foward P/E19.66
Dividend (Yield %)N/A
Ex-Dividend DateN/A



Financial Details


According to Boston Scientific Corporation's financial reports the company's revenue in 2021 were 11.89B an decrease( +22.22%) over the years 2020 revenue that were of 9.91B. In 2021 the company's total earnings were 1.04B while total earnings in 2020 were -82M(-1319.51%).


Loading ...



Organization

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable c... ardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Market Cap:
55.45B
Revenue:
11.89B
Total Assets:
32.23B
Total Cash:
1.93B


News about "Boston Scientific Corporation"

Is It Time To Consider Buying Boston Scientific Corporation (NYSE:BSX)?

Source from : Yahoo Finance - 5 days ago

Boston Scientific Corporation (NYSE:BSX) received a lot of attention from a substantial price movement on the NYSE over the last few months, increasing to US$43.46 at one point, and dropping to ...See details»


boston-scientific-co-nysebsx-shares-acquired-by-great-valley-advisor-group-inc-image

Boston Scientific Co. (NYSE:BSX) Shares Acquired by Great Valley Advisor Group Inc.

Source from : Defense World - 2 days ago

Great Valley Advisor Group Inc. grew its holdings in Boston Scientific Co. (NYSE:BSX โ€“ Get Rating) by 54.5% in the 2nd quarter, according to the company in its most recent Form 13F filing with the ...See details»


Artisan Partners Believes that Boston Scientific Corporation (BSX) is Well-Positioned in the Market

Source from : Insider Monkey - 5 days ago

Artisan Partners discussed stocks like Boston Scientific Corporation (NYSE:BSX) in the second quarter investor letter. Headquartered in Marlborough, Massachusetts, Boston Scientific Corporation ...See details»


Here's Why You Should Retain Boston Scientific (BSX) For Now

Source from : Yahoo - 12 days ago

Boston Scientific Corporation BSX is gaining substantial contributions from its notable buyouts. The company posted better-than-expected results for the second quarter of 2022. The robust ...See details»


veriti-management-llc-grows-holdings-in-boston-scientific-co-nysebsx-image

Veriti Management LLC Grows Holdings in Boston Scientific Co. (NYSE:BSX)

Source from : Defense World - 5 days ago

Veriti Management LLC increased its stake in Boston Scientific Co. (NYSE:BSX โ€“ Get Rating) by 1.9% in the second quarter, according to the company in its most recent disclosure with the Securities and ...See details»


Boston Scientific: Making the Most of Its First 25 Years

Source from : MD&M East - 6 days ago

The first magazine covering device manufacturing, MD&DI, has just begun publication. In this uncertain, diversified, decentralized environment, Boston Scientific Corp. is founded. The new company, a ...See details»


Boston Scientific Gets FDA Approval For Expanded Labeling Of WATCHMAN FLX LAAC Device

Source from : Finanznachrichten - 2 days ago

WASHINGTON (dpa-AFX) - Medical technology company Boston Scientific Corp. (BSX) announced Tuesday that it has received U.S. Food and Drug Administration approval for expanded labeling of WATCHMAN ...See details»


health-data-company-truveta-inks-partnership-with-boston-scientific-releases-covid-19-data-image

Health data company Truveta inks partnership with Boston Scientific, releases COVID-19 data

Source from : Geekwire on MSN - 5 days ago

Seattle-area health data startup Truveta announced a collaboration Tuesday with Boston Scientific, a leading medical device company.See details»


Boston Scientific Snags Expanded Labeling FDA Nod for LAAC Device

Source from : MD&M East - 5 days ago

Boston Scientific Corporation today announced it has received FDA approval to expand the instructions for use in labeling the current-generation WATCHMAN FLX Left Atrial Appendage Closure (LAAC) ...See details»


Cramer's lightning round: I like Boston Scientific over Medtronic

Source from : CNBC - 9 days ago

Loading chart... Boston Scientific Corp: "I've worked and seen doctors with their stuff. It is breakthrough. BSX is a much better company than Medtronic." Loading chart... Dow Inc: "Don't buy it back.See details»


urinary-incontinence-market-to-exhibit-cagr-of-68-from-2022-to-2030-caldera-medical-boston-scientific-corporation-convatec-group-plc-coloplast-image

Urinary Incontinence Market to Exhibit CAGR of 6.8% from 2022 to 2030 | Caldera Medical, Boston Scientific Corporation, ConvaTec Group plc, Coloplast

Source from : Medgadget - 2 days ago

Development of innovative urinary incontinence devices, surge in demand for minimally invasive procedures, and rise in risk of urological disorders drive the global urinary incontinence device market.See details»


truveta-announces-collaboration-with-boston-scientific-image

Truveta Announces Collaboration with Boston Scientific

Source from : Endovascular Today - 5 days ago

Truveta announced a strategic collaborative agreement with Boston Scientific Corporation whereby Boston Scientific researcher ...See details»


Why Jim Cramer Says He Likes This Stock Over Medtronic

Source from : Benzinga.com - 9 days ago

On CNBCโ€™s "Mad Money Lightning Round," Jim Cramer said Boston Scientific Corporation BSX is a much better company than Medtronic plc MDT. When asked about Dow Inc. DOW, Cramer said, "Donโ€™t buy ...See details»


Urinary Incontinence Treatment Devices Market Business overview 2022, and Forecast to 2029 | Boston Scientific Corporation, Promedon Group

Source from : MarketWatch - 11 days ago

The Urinary Incontinence Treatment Devices Market is expected to grow at a CAGR of 3.6% during the forecast period 2022-2028. Top Companies: Boston Scientific Corporation, Promedon Group, Medtronic ...See details»